Back to Trades
Sell4
Denali Therapeutics Inc.
DNLI
Total Value
$51.7K
Net $51.7K sold
Sales
$51.7K
2 transactions
Company Information
- Company Name
- Denali Therapeutics Inc.
- Ticker Symbol
- DNLI
- CIK
- 0001714899
Insider Information
- Name
- Ho Carole
- Role
- Chief Medical Officer
- Location
- SOUTH SAN FRANCISCO, CA
Officer
Filing Details
- Filing Date
- Aug 14, 2025
- Transaction Date
- Aug 12, 2025
- Accession Number
- 0001714899-25-000176
- Form Type
- 4
- Net Trading Amount
- -$51.7K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | 2,937 | $13.58 | Sale | $39.9K |
| Aug 13, 2025 | Common Stock | 806 | $14.64 | Sale | $11.8K |
Footnotes
- (F1)Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
- (F2)The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.34 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- (F3)Includes 128,405 Unvested RSUs.
- (F4)The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted December 11, 2024.
- (F5)The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
- (F6)The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.